St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4

By D. Dürr, Bruno Stieger, G. Kullak-Ublick, K. Rentsch, H. Steinert, P. Meier, K. Fattinger. Clinical pharmacology and therapy, 2000

601 citations recorded by the source corpus.

Subfields: Oncology, Pharmacology, Plant Science

View Paper: https://www.semanticscholar.org/paper/746bba4b1c319bb64a196acb63bd80e104037baf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. Y. Chiang

In Pharmacology

1. B. Goodwin
2. S. Kliewer
3. T. Willson

Citations in the corpus

• Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance (2004, background): “Table I provides a comprehensive list of compounds that are substrates, inhibitors, or inducers of P-gp.(11-74) The range of substrates transported by P-gp is broad and includes a variety of pharmacologically distinct agents used in cancer chemotherapy, hypertension, allergy, infection, immunosuppre”
• The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. (2002, background): “intestine (112) and enhanced the metabolism of oral contra-”